Does anyone have new guidelines or protocols they are using in view of the Black Box Warning for erythropoietin? We have spoken with pharmaceutical company reps, done a literature search, and even tried Hospital Information Services, with vrtually no success.
Thank you for whatever you can share.
Liz

__________________
Liz Crum, MSN, RN, CCRN
Coordinator, Center for Bloodless Medicine and Surgery
Hackensack University Medical Center
30 Prospect Ave.
Hackensack, NJ 07601
Phone:201-996-2963
Fax: 201-336-8635